H. Patel

Comparison of Real-World Treatment Outcomes With Vedolizumab Versus Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease

D. Latrémouille-Viau, R. Burne, S. Adsul, 2019, Crohn's & Colitis 360.

P491 Efficacy and safety outcomes of long-term treatment with filgotinib 200 mg among patients with Ulcerative Colitis: An interim analysis of SELECTIONLTE

G. Rogler, L. Peyrin-Biroulet, M. Faes, 2022, Journal of Crohn's and Colitis.